KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Working Capital Changes: 2015-2025

Historic Other Working Capital Changes for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $25.5 million.

  • Medpace Holdings' Other Working Capital Changes fell 21.45% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.4 million, marking a year-over-year increase of 7.36%. This contributed to the annual value of $150.7 million for FY2024, which is 55.18% up from last year.
  • As of Q3 2025, Medpace Holdings' Other Working Capital Changes stood at $25.5 million, which was down 68.32% from $80.6 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Other Working Capital Changes registered a high of $80.6 million during Q2 2025, and its lowest value of -$15.0 million during Q1 2023.
  • Its 3-year average for Other Working Capital Changes is $33.8 million, with a median of $32.5 million in 2024.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 743.50% in 2021, then crashed by 234,209.74% in 2023.
  • Quarterly analysis of 5 years shows Medpace Holdings' Other Working Capital Changes stood at $40.8 million in 2021, then grew by 9.83% to $44.8 million in 2022, then declined by 8.25% to $41.1 million in 2023, then decreased by 3.55% to $39.6 million in 2024, then fell by 21.45% to $25.5 million in 2025.
  • Its Other Working Capital Changes stands at $25.5 million for Q3 2025, versus $80.6 million for Q2 2025 and $17.6 million for Q1 2025.